Glo1 expression was assessed by immunohistochemistry in paraffin-embedded sections from 60 patients who had undergone radical prostatectomy for either localized (T2) or locally advanced (T3) prostate cancer (PCa). The gene discussed is GLO1; the disease is prostate carcinoma.